Michelsen LG, Hug Jr CC (December 1996). "The pharmacokinetics of remifentanil". Journal of Clinical Anesthesia. 8 (8): 679–82. doi:10.1016/s0952-8180(96)00179-1. PMID8982900.
Panlilio LV, Schindler CW (May 2000). "Self-administration of remifentanil, an ultra-short acting opioid, under continuous and progressive-ratio schedules of reinforcement in rats". Psychopharmacology. 150 (1): 61–6. doi:10.1007/s002130000415. PMID10867977. S2CID21623038.
Baylon GJ, Kaplan HL, Somer G, Busto UE, Sellers EM (December 2000). "Comparative abuse liability of intravenously administered remifentanil and fentanyl". Journal of Clinical Psychopharmacology. 20 (6): 597–606. doi:10.1097/00004714-200012000-00002. PMID11106130.
Feldman PL, Chorghade MS (July 2006). Chorghade MS (ed.). "Discovery and development of the ultrashort-acting analgesic remifentanil". Drug Discovery and Development. 18. Wiley Online Library: 339–342. doi:10.1002/0471780103. ISBN9780471398486.
espacenet.com
worldwide.espacenet.com
US 5866591, Gatlin LA, Heiman SA, Lewis JS, "Stable formulations of remifentanil", issued 2 February 1999
Knapik M, Knapik P, Nadziakiewicz P, Misiołek H, Saucha W, Walaszczyk M, Dyaczyńska-Herman A (August 2006). "Comparison of remifentanil or fentanyl administration during isoflurane anesthesia for coronary artery bypass surgery". Medical Science Monitor. 12 (8): PI33–8. PMID16865075.
Michelsen LG, Hug Jr CC (December 1996). "The pharmacokinetics of remifentanil". Journal of Clinical Anesthesia. 8 (8): 679–82. doi:10.1016/s0952-8180(96)00179-1. PMID8982900.
Hoke JF, Cunningham F, James MK, Muir KT, Hoffman WE (April 1997). "Comparative pharmacokinetics and pharmacodynamics of remifentanil, its principle metabolite (GR90291) and alfentanil in dogs". The Journal of Pharmacology and Experimental Therapeutics. 281 (1): 226–232. PMID9103501.
Panlilio LV, Schindler CW (May 2000). "Self-administration of remifentanil, an ultra-short acting opioid, under continuous and progressive-ratio schedules of reinforcement in rats". Psychopharmacology. 150 (1): 61–6. doi:10.1007/s002130000415. PMID10867977. S2CID21623038.
Baylon GJ, Kaplan HL, Somer G, Busto UE, Sellers EM (December 2000). "Comparative abuse liability of intravenously administered remifentanil and fentanyl". Journal of Clinical Psychopharmacology. 20 (6): 597–606. doi:10.1097/00004714-200012000-00002. PMID11106130.
Panlilio LV, Schindler CW (May 2000). "Self-administration of remifentanil, an ultra-short acting opioid, under continuous and progressive-ratio schedules of reinforcement in rats". Psychopharmacology. 150 (1): 61–6. doi:10.1007/s002130000415. PMID10867977. S2CID21623038.